The ASCO-ONS standards for administration of antineoplastic therapy provide a comprehensive framework for ensuring patient ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

A weight loss drug recently approved for use ... Mounjaro, which treats type 2 diabetes, has recently been approved for ...

The way the California electorate came down Tuesday on the 10 measures on the statewide ballot shows the enormous fallacy of ...

The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

However, sports and medicine have changed dramatically since the era of doping tragedies such as Tom Simpson. Most recent ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...

This is the second time in 2024 that on the same day that MHRA approved a new disease-modifying therapy (DMT) for Alzheimer’s disease, the initial recommendation from NICE has been to not recommend ...

Fiona Carragher, chief policy and research officer at Alzheimer’s Society, described NICE’s latest decision as “disheartening”, but noted that, with around 20 AD drugs in late-stage clinical trials, ...

Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP ... targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October).

Donanemab marks a significant advancement in Alzheimer’s treatment, but NHS patients face a setback with NICE's rejection of its cost-effectiveness. A new Alzheimer's treatment, donanemab, has been ...